Companies × risks
AbbVie
AbbVie deploys AI/ML across R&D and clinical operations through its ARCH platform and partnerships (BigHat, Pega/Accenture AIDEN). It also develops specialised models for drug discovery and pharmacovigilance, with published ML modelling work by AbbVie researchers.
We reviewed 2 public documents from AbbVie and found it acknowledges none of the 24 AI risks we looked for.
Sector: Agriculture, Mining, Construction and Manufacturing; Chemicals & pharmaceutical manufacturing
Roles: AI deployer; Specialized AI developer
Documents we reviewed
- AbbVie 2024 Annual Report on Form 10-K (Annual report, 2025)
- AbbVie 2025 Proxy Statement (Notice of 2025 Annual Meeting of Stockholders) (Investor materials, 2025)